Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Rutgers, The State University of New Jersey
Erasca, Inc.
Novartis
Mayo Clinic
Eli Lilly and Company
Merck Sharp & Dohme LLC
Ascendis Pharma A/S
Werewolf Therapeutics, Inc.
Wake Forest University Health Sciences
M.D. Anderson Cancer Center
Royal Marsden NHS Foundation Trust
Merck Sharp & Dohme LLC
Regeneron Pharmaceuticals
University of Wisconsin, Madison
Institut Curie
BioInvent International AB
Memorial Sloan Kettering Cancer Center
NovoCure Ltd.
Memorial Sloan Kettering Cancer Center
University of California, San Diego
Memorial Sloan Kettering Cancer Center
Mirati Therapeutics Inc.
Immuneering Corporation
invoX Pharma Limited
BeiGene
BioAtla, Inc.
Providence Health & Services
Carisma Therapeutics Inc
NextCure, Inc.
Salubris Biotherapeutics Inc
ImmunSYS, LLC
Rampart Health, L.L.C.